Product Reports Resources Pricing Login Book a demo

Novocardia

Health Tech & Medtech · New York City, United States · Founded 2020

Building a network of America’s leading cardiologists to improve cardiovascular health across America MoreLess

Novocardia is a pioneering startup in the healthcare sector, specifically focusing on cardiovascular care. The company is dedicated to improving cardiac health across America by building a nationwide network of top cardiologists. Novocardia operates in the value-based care market, which means they focus on providing high-quality care while keeping costs reasonable. This approach results in better patient outcomes and higher satisfaction among both patients and clinicians.

The business primarily serves patients with cardiovascular conditions, aiming to deliver the right care at the right time and place. They achieve this through a combination of advanced technology and data analytics. Novocardia uses electronic health records (EHR) and payer claims data to track patient outcomes, healthcare utilization, and costs. This helps them to identify and address patient needs promptly.

One of Novocardia's key offerings is their Care Transitions Intervention, which ensures smooth transitions between different healthcare settings. This helps to prevent unnecessary hospitalizations and emergency room visits, thereby reducing healthcare costs. They also offer a Longitudinal Heart Failure Program, providing comprehensive support for patients with heart failure.

Novocardia's business model revolves around value-based care, where they get paid based on patient outcomes rather than the volume of services provided. This model incentivizes them to keep patients healthy and satisfied. They make money through partnerships with healthcare providers and payers, leveraging their proprietary technology and actuarial models to optimize care delivery and cost management.

In summary, Novocardia is revolutionizing cardiovascular care by combining a network of leading cardiologists with cutting-edge technology and a value-based care approach. This ensures that patients receive high-quality, timely care while keeping costs in check.

Keywords: cardiovascular care, value-based care, cardiologists, patient outcomes, healthcare technology, data analytics, EHR, cost management, heart failure support, care transitions.

Company overview

Novocardia company information

The essential company record, classifications and operating signals in one place.

Status
Acquired
Founded
2020
Headquarters
New York City, United States
Employees
6
Open positions
None listed
Dealroom signal
60.5
sub industryHealth Platformbusiness modelSaaSindustryHealthsectorHard Techclient focusb2b

Valuation & funding

Novocardia funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITIONOther financing Apr 2023 $0 Cardiovascular Associates of America
SERIES AOther financing Jun 2021 $54M $215M Deerfield
Showing 2 recorded eventsUnlock the complete deal history →

Growth signals

Novocardia website traffic

Latest recorded traffic for Novocardia is 1.4K monthly website visits, up 0% over the last three months. Novocardia's team declined 87.2% over the past year.

Latest monthly visits1.4K 3-month web change0% 1-year team growth-87.2%
Monthly website visits32 observations · Jan 2022–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Novocardia compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

Novocardia's talent

Book a demo to see the people
Team profiled 12 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

2 investors on Novocardia's cap table

Sourced from Dealroom's funding and investor records.

Series A 1 investor entered at this stage
Deerfield
Other known 1 additional known investor
Cardiovascular Associates of America

Global footprint

Where Novocardia has talent and traffic

Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

In the news

Latest news about Novocardia

Recent press, funding announcements, and product moves mentioning Novocardia — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Novocardia

An AI-synthesized read of the highest-engagement posts about Novocardia on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Novocardia’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.